-9.30 -138.48 Change +/(-) Unit : million baht • Revenue of Q 1/2019 is less than of both Q 4/2018 and Q1/2018 because of the followings: o Low purchasing power in domestic market causes our domestic

. Statement of Comprehensive Income Total Revenues (Million Baht) Quarterly Change 1/2019 1/2018 % Sales Domestic Sales 88.4 106.6 (17.1) Export Sales 295.8 295.2 0.2 Total Sales 384.2 401.8 (4.4) Foreign

baht or 0.4 percent compared to non-current assets as of December 31, 2018. The major change was mainly from the decreased of investment property 0.9 million baht. 2 (2) Total Liabilities Company total

) operating results based on its reviewed consolidated financial statements ended 30 June 2019 as follows. Highlights on Q2-2019 Operating results Unit : Million Baht Q2-19 Q2-18 Q1-19 % Change Amount % Amount

-0.07 2.51 0.97 -0.90 -108.78 Change +/(-) Unit : million baht • The revenue of Q2/2019 is increased by 26.85 million baht comparing with Q1/2019 because higher revenue from both domestic market and

nearly the same, there is no significant change. Service Income In 2019, the company’s and subsidiaries’ service income was totally Baht 5.94 million, whereas none of them in 2018, increasing Baht 5.94

results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech

(3 month period) Change Revenues from hospital operations 213.42 142.19 +50.09% Gross Profit 93.30 52.15 +78.91% Profit to equity holders of the company 38.44 22.33 +72.14% Six Month Period Operational

financial instruments 100.85 (33.27) 100.72 (33.40) Shares of gain from investments in an associate and a joint venture 1.23 2.54 0.00 0.00 Gain from change in a joint venture proportion 0.00 (8.80) 0.00 0.00

percent compared to non-current assets as of December 31, 2017. The major change was mainly from the dereased of Investment Property 13.8 million baht while Cost of landfill preparation increased 7.9